Please use this identifier to cite or link to this item: http://hdl.handle.net/2445/191002
Title: Yeast prions form infectious amyloid inclusion bodies in bacteria
Author: Espargaró Colomé, Alba
Villar Piqué, Anna
Sabaté Lagunas, Raimon
Ventura, Salvador
Keywords: Prions
Bacteris
Proteïnes
Prions
Bacteria
Proteins
Issue Date: 25-Jun-2012
Publisher: BioMed Central
Abstract: Background Prions were first identified as infectious proteins associated with fatal brain diseases in mammals. However, fungal prions behave as epigenetic regulators that can alter a range of cellular processes. These proteins propagate as self-perpetuating amyloid aggregates being an example of structural inheritance. The best-characterized examples are the Sup35 and Ure2 yeast proteins, corresponding to [PSI+] and [URE3] phenotypes, respectively. Results Here we show that both the prion domain of Sup35 (Sup35-NM) and the Ure2 protein (Ure2p) form inclusion bodies (IBs) displaying amyloid-like properties when expressed in bacteria. These intracellular aggregates template the conformational change and promote the aggregation of homologous, but not heterologous, soluble prionogenic molecules. Moreover, in the case of Sup35-NM, purified IBs are able to induce different [PSI+] phenotypes in yeast, indicating that at least a fraction of the protein embedded in these deposits adopts an infectious prion fold. Conclusions An important feature of prion inheritance is the existence of strains, which are phenotypic variants encoded by different conformations of the same polypeptide. We show here that the proportion of infected yeast cells displaying strong and weak [PSI+] phenotypes depends on the conditions under which the prionogenic aggregates are formed in E. coli, suggesting that bacterial systems might become useful tools to generate prion strain diversity.
Note: Reproducció del document publicat a: https://doi.org/10.1186/1475-2859-11-89
It is part of: Microbial Cell Factories, 2012, vol. 11, p. 89
URI: http://hdl.handle.net/2445/191002
Related resource: https://doi.org/10.1186/1475-2859-11-89
ISSN: 1475-2859
Appears in Collections:Articles publicats en revistes (Farmàcia, Tecnologia Farmacèutica i Fisicoquímica)

Files in This Item:
File Description SizeFormat 
642560.pdf2.48 MBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.